This is a message on behalf of the Department of Health and Social Care
Following advance notice in February’s Drug Tariff of the new Part VIIIA Category H (NHS Electronic Drug Tariff), the following products will be moving from Category C to Category H, effective from March 2026:
- Cinchocaine 5mg / Hydrocortisone 5mg suppositories
- Doxazosin 4mg modified-release tablets
- Etodolac 600mg modified-release tablets
- Isosorbide mononitrate 25mg modified-release capsules
- Nicotine 4mg medicated chewing gum sugar free
- Omeprazole 10mg dispersible gastro-resistant tablets
- Omeprazole 20mg dispersible gastro-resistant tablets
- Omeprazole 40mg dispersible gastro-resistant tablets
- Pseudoephedrine hydrochloride 60mg tablets
- Ursodeoxycholic acid 500mg tablets
- Verapamil 120mg modified-release tablets